Clinilabs invites you to their event
About this event
We know how unsettling these times are for everyone - especially for those considering ways to manage the demands of ongoing and future CNS clinical trials.
Despite these challenges, we know now more than ever, the importance of the scientific community and the medical research field. Join our team members to hear how sponsors and investigators are approaching contingency planning in today's unique environment.
Hosted by
Ms. Jeanine Falinski, VP of Strategy and Corporate Development, has more than 20 years of experience in the pharmaceutical industry. Jeanine graduated from Emerson College with a degree in New Media and Marketing, later on receiving her MBA in Pharmaceutical Management from Drexel University.
Gary Zammit is a neuroscientist and sleep specialist who founded Clinilabs Drug Development Corporation in 2001. He is widely recognized as a key opinion leader in the field of sleep medicine, and has been involved in the development of new drugs to treat sleep disorders such as narcolepsy, insomnia, excessive sleepiness, and circadian rhythm disorders.
Dr. Kirby, a board certified neurologist, business founder and CEO, and a specialist consultant in CNS drug development, medical devices & laboratory developed diagnostics.
Ms. Allison House-Gecewicz brings over 20 years of experience in clinical trials project management as well as 5 years of experience in clinical monitoring and trial coordination.
We are a global, full-service contract research organization (CRO), the only one focused exclusively on central nervous system (CNS) drug development. We are dedicated to bringing new therapies to patients living with mental health, neurological and substance abuse disorders.
